Richard A Gonzalez has sold ABBV and made no open-market buys since May 2016
Executive Chair at AbbVie Inc.
SEC CIK 0001239127 · Filings on SEC.gov ↗
$0Bought
$233.5MSold
NoneLast buy
Every filing
16 filings since May 2016, newest first
ABBVSell
Abbvie Inc.
Executive Chair
$12.4M−13.0%Aug 7
ABBVSell
Abbvie Inc.
Executive Chair
$49.5M−36.0%Jul 19
ABBVSell
Abbvie Inc.
Chair and CEO
$24.6M−21.0%Mar 1
ABBVSell
Abbvie Inc.
Chair and CEO
$11.7M−12.0%Aug 2
ABBVSell
Abbvie Inc.
Chair and CEO
$21.5M−30.0%Dec 10
ABBVSell
Abbvie Inc.
Chair and CEO
$18.5M−30.0%Mar 2
ABBVSell
Abbvie Inc.
Chair and CEO
$22.4M−40.0%Nov 12
ABBVSell
Abbvie Inc.
Chair and CEO
$1.5M−5.0%Dec 13
ABBVSell
Abbvie Inc.
Chair and CEO
$976K−3.0%Mar 2
ABBVSell
Abbvie Inc.
Chair and CEO
$20.5M−44.0%Nov 24
ABBVSell
Abbvie Inc.
Chair and CEO
$13.7M−41.0%Aug 8
ABBVSell
Abbvie Inc.
Chair and CEO
$6.2M−24.0%Aug 4
ABBVSell
Abbvie Inc.
Chair and CEO
$4.7M−20.0%May 23
ABBVSell
Abbvie Inc.
Chair and CEO
$4.6M−17.0%Mar 10
ABBVSell
Abbvie Inc.
Chair and CEO
$18.2M−45.0%Jun 3
ABBVSell
Abbvie Inc.
Chair and CEO
$2.5M−10.0%May 13
Filings come from SEC EDGAR. Not investment advice.